ResearchAndMarkets forecasts proteomic biomarker analytics to grow 10-15% annually, driven by cancer diagnostics and drug ...
GLP-1 drugs show a startling effect on aging, according to a new study.
The marked differences of how a JAK inhibitor and an anti-IL-4 inhibitor affect proteomics in the treatment of AD provide new ...
A comparative proteomics pipeline and the first CRISPR-Cas9 gene editing in Fasciola hepatica juveniles have identified three ...
Individuals interested in listening to the conference call may do so by joining the live webcast on the Investors section of the Quantum-Si website under Events and Presentations. Alternatively, ...
Morning Overview on MSN
Loneliness, low income and other unfavorable social conditions were tied to 2.4 times the dementia risk in people with type 2 diabetes
Among 10,071 people with type 2 diabetes in the UK Biobank, those living with the most unfavorable social conditions had about 2.4 times the dementia risk of those with the most favorable conditions, ...
A comprehensive systematic review of 49 pre-treatment cohorts identifies circulating protein signatures, including ...
Proteomic analysis identifies a 26-protein signature of continued ovarian remodeling across the decades following menopause.
Plants—like people—come in all shapes and sizes. And just like scientists want to understand the components of the human body ...
Blood protein signatures could help distinguish primary biliary cholangitis from MASLD and healthy individuals.
Thermo Fisher Scientific (NYSE:TMO) is expanding its presence in proteomic biomarker analytics and immuno-oncology ...
MarketsandMarkets™ projects the global AI in drug discovery market to grow from USD 5.09 billion in 2026 to USD 17.56 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results